ACA
VRCA icon

Avoro Capital Advisors’s Verrica Pharmaceuticals VRCA Stock Holding History

Avoro Capital Advisors’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-400,000
Closed -$29.2M – 41
2024
Q2 		$29.2M Hold
400,000
– – 0.39% 33
2024
Q1 		$23.7M Hold
400,000
– – 0.28% 43
2023
Q4 		$29.3M Buy
400,000
+104,594
+35% +$4.3M 0.4% 32
2023
Q3 		$11.5M Hold
295,406
– – 0.18% 38
2023
Q2 		$17M Buy
295,406
+30,406
+11% +$1.85M 0.23% 35
2023
Q1 		$17.2M Buy
+265,000
New +$16M 0.26% 32

Other funds holding VRCA

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return